Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Tyra Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 49 | 46 | −3 |
| Shares | 35.7M | 35.2M | −453.5K (−1.3%) |
| Value | $313.8M | $267.8M | −$45.9M (−14.6%) |
New holders (1)
Institutions that held Tyra Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nisa Investment Advisors, LLC | 16 | $0 | 0.00% |
Sold out (4)
Institutions that held Tyra Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Cormorant Asset Management, LP | 743,988 | $6.54M |
| Janus Henderson Group PLC | 682,018 | $6.01M |
| Wells Fargo & Company | 39 | $0 |
| Ellevest, Inc. | 27 | $0 |